Posted on May 28, 2019 by Sitemaster
Whether whole pelvic radiation therapy (WPRT) is beneficial for men newly diagnosed with Gleason grade 9/10 (Grade Group 5) is controversial. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: 10, 9, Gleason, pelvic, primary, radiation, score, whole | 1 Comment »
Posted on October 21, 2018 by Sitemaster
New data from the ongoing STAMPEDE trial in the UK and Switzerland has now confirmed that ablative radiation of the prostate itself (debulking of the primary tumor) improves overall survival (OS) in men newly diagnosed with metastatic prostate cancer who have a low metastatic disease burden but not in those with higher burden of disease. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen, debulking, deprivation, docetaxel, metastasis, primary, radiation, therapy, tumor | 7 Comments »
Posted on October 1, 2018 by Sitemaster
The term “debulking” denotes the radical treatment (via prostatectomy or radiation therapy) of the cancerous prostate — lmost always in newly diagnosed patients — after distant metastases have been discovered. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: debulking, primary, prostatectomy, radiation, therapy, trial, tumor | 24 Comments »
Posted on September 4, 2018 by Sitemaster
Over the years, a good deal of data has been accumulated suggesting that local treatment (ablation) of the primary tumor may have benefit in the long-term outcomes of men with metastatic prostate cancer at time of initial diagnosis. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ablation, metastatic, newly diagnosed, primary, tumor | 9 Comments »
Posted on August 7, 2017 by Sitemaster
One really has to wonder whether we are still treating elderly men, initially diagnosed with organ-confined prostate cancer, with first-line or “primary” androgen deprivation therapy ADT)! And if we are, why on Earth is that? … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: ADT, androgen, appropriate, deprivation, elderly, organ-confined, primary | 4 Comments »
Posted on April 17, 2017 by Sitemaster
A newly published article on the Journal of the American Board of Family Medicine offers some helpful guidance to primary care physicians on the subject of prostate cancer diagnosis and its management. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: care, Diagnosis, education, patient, physician, primary, referral | Leave a comment »
Posted on December 23, 2015 by Sitemaster
In a recent commentary, the Sitemaster mentioned some common adverse effects of radical prostatectomy, some of which (e.g., perceived penile shrinkage, climacturia) are seldom mentioned by urologists to prospective patients, and are not routinely included in standardized quality-of-life questionnaires. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: complications, intensity-modulated, primary, radiation, side effects | 8 Comments »
Posted on September 15, 2015 by Sitemaster
Primary melanoma of the prostate is so rare that only five cases of this disorder have ever been reported in the medical literature — and your sitemaster had never even heard of this form of prostate cancer prior to seeing the care report referred to below. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: melanoma, primary, prostate | 4 Comments »
Posted on January 26, 2015 by Sitemaster
The most widely used definition of biochemical failure after primary radiation therapy is the so-called “Phoenix” definition. It’s called that because it was adopted by consensus at a meeting of the American Society for Radiation Oncology (ASTRO) in Phoenix, AZ, in 2005. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: biochemical, failure, primary, radiation therapy | 3 Comments »
Posted on July 15, 2014 by Sitemaster
In another paper just published on-line in JAMA Internal Medicine this week, the authors have provided additional data indicating — once again — the lack of any value of primary androgen deprivation therapy (ADT) in the management of early-stage, localized prostate cancer among older patients. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen, delayed, deprivation, early, hormone, primary, therapy | Leave a comment »
Posted on March 17, 2014 by Sitemaster
Data from a large, retrospective study, reported in the Journal of Clinical Oncology, suggest something that many expert clinicians and patients have long suspected … that early use of androgen deprivation therapy (ADT) alone is not an effective treatment for most men with early stage prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen, deprivation, primary, Treatment | 18 Comments »
Posted on December 2, 2013 by Sitemaster
There has long been an unanswered question about the value of “debulking” of the primary tumor in men who are initially diagnosed with advanced forms of prostate cancer — i.e., surgical removal of the prostate or some form of definitive radiation therapy of the primary tumor. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: debulking, metastatic, primary, tumor | 3 Comments »
Posted on December 26, 2011 by Sitemaster
A recent case report by Humphrey in the Journal of Urology offers information about a 67-year-old patient found to have a form of prostate cancer known as angiosarcoma of the prostate. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: angiosarcoma, primary, sarcoma | 4 Comments »
Posted on April 27, 2010 by Sitemaster
Many patients with no specific evidence of metastatic disease now receive primary androgen deprivation therapy (PADT) much earlier than was the case before the availability of the PSA test. This includes patients who get hormone therapy for a rising PSA after other forms of first-line therapy and patients who receive hormone therapy as their first-line treatment. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen deprivation therapy, hormone therapy, primary | 4 Comments »
Posted on May 27, 2009 by Sitemaster
Today’s news reports cover such items as:
- Identification of prostate cancer cells in urine
- Prognosis after radiation therapy
- The effect of bisphenol A on prostate cancer therapy
- The appropriateness of primary androgen deprivation for localized prostate cancer
- Data from clinical trials of Phase II clinical trial of docetaxel + samarium-153 lexidronam and cyclophosphamide + dexamethasone in late stage disease … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: ADT, androgen deprivation therapy, bisphenol A, cyclophosphamide, Diagnosis, docetaxel, primary, prognosis, risk, samarium-153 | Leave a comment »